Local News

FDA Sets Date for Decision on Salix Colonoscopy Prep Product

Posted June 22, 2006

— The Food and Drug Administration expects to make a decision about whether to approve a drug for use as a colonoscopy prep from

Salix Pharmaceuticals

by Aug. 2.

The FDA told Salix in April that manufacturing issues needed to be resolved before approval would be granted. In a statement Wednesday, Salix said it had worked with Norgine, the drug's European-based developer and producer, to resolve the FDA's concerns.

The drug, called MoviPrep, is intended for use as a bowel cleansing agent before a colonoscopy.

Salix said it expected the FDA to approve the drug and launch sales later this year.

Comments

Please with your WRAL.com account to comment on this story. You also will need a Facebook account to comment.

Oldest First
View all